Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 2020

Potassium

Potassium Citrate

Approved 29 Jun 2020OralTablet, extended release

The FDA lists this product in 26 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: POTASSIUM CITRATE 15MEQ

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA203546-002 · Prescription
POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA203546-003 · Prescription
POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA203546-001 · Prescription
POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA212779-001 · Prescription
POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA212779-002 · Prescription
POTASSIUM CITRATE 15MEQ · Tablet, extended releaseThis page
POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA212799-001 · Prescription
POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA214426-002 · Prescription
POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA214426-003 · Prescription
POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA214426-001 · Prescription

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA209758-002 · Prescription

POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA209758-003 · Prescription

POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA209758-001 · Prescription

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA077440-002 · Prescription

POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA077440-001 · Prescription

POTASSIUM CITRATE 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solutionNDA019647-002 · Discontinued

POTASSIUM CITRATE 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solutionNDA019647-001 · Discontinued

POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA214420-003 · Prescription

POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA214420-001 · Prescription

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA214420-002 · Prescription

POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA206813-003 · Prescription

POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA206813-001 · Prescription

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA206813-002 · Prescription

POTASSIUM CITRATE 15MEQ · Tablet, extended releaseANDA213986-003 · Discontinued

POTASSIUM CITRATE 5MEQ · Tablet, extended releaseANDA213986-001 · Discontinued

POTASSIUM CITRATE 10MEQ · Tablet, extended releaseANDA213986-002 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA212799.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Potassium Citrate
Drug class: Potassium
Route: Oral
Dosage form: Tablet, extended release
Applicant: Bionpharma
Status: Prescription
FDA approval: 29 Jun 2020
Application: ANDA212799-002
RxCUI: 54993